Literature DB >> 33569366

COVID-19 and Teleneurology in Sub-Saharan Africa: Leveraging the Current Exigency.

Philip Babatunde Adebayo1, Olusegun John Oluwole2, Funmilola Tolulope Taiwo3.   

Abstract

Africa has over 1.3 billion inhabitants, with over 60% of this population residing in rural areas that have poor access to medical experts. Despite having a ridiculously huge, underserved population, very few African countries currently have any form of sustained and organized telemedicine practice, and even fewer have dedicated tele-neurology services. The ongoing COVID-19 pandemic has proved to be one of the most significant disruptors of vital sectors of human endeavor in modern times. In the healthcare sector, there is an increasing advocacy to deliver non-urgent care via telemedicine. This paper examined the current state of tele-neurology practice and infrastructural preparedness in sub-Saharan Africa. Currently, there is over 70% mobile phone penetration in most of the countries and virtually all of them have mobile internet services of different technologies and generations. Although the needed infrastructure is increasingly available, it should be improved upon. We have proposed the access, costs, ethics, and support (ACES) model as a bespoke, holistic strategy for the successful implementation and advancement of tele-neurology in sub-Saharan Africa.
Copyright © 2021 Adebayo, Oluwole and Taiwo.

Entities:  

Keywords:  Africa; COVID-19; coronavirus; telehealth; teleneurology

Mesh:

Year:  2021        PMID: 33569366      PMCID: PMC7868436          DOI: 10.3389/fpubh.2020.574505

Source DB:  PubMed          Journal:  Front Public Health        ISSN: 2296-2565


  41 in total

1.  Teleneurology as a Solution for Outpatient Care During the COVID-19 Pandemic.

Authors:  Marisa P McGinley; Daniel Ontaneda; Zhini Wang; Malory Weber; Steven Shook; Matthew Stanton; Robert Bermel
Journal:  Telemed J E Health       Date:  2020-06-16       Impact factor: 3.536

2.  UK neurology response to the COVID-19 crisis.

Authors:  Catherine J Mummery; Christopher M Kipps
Journal:  Clin Med (Lond)       Date:  2020-04-30       Impact factor: 2.659

3.  Teleneurology in sub-Saharan Africa: Experience from a long lasting HIV/AIDS health program (DREAM).

Authors:  Massimo Leone; Fabio Massimo Corsi; Fabio Ferrari; Darlington Thole; Giuseppe Didato; Maria Cristina Marazzi; Paola Germano; Michelangelo Bartolo
Journal:  J Neurol Sci       Date:  2018-06-18       Impact factor: 3.181

4.  Practice guidelines for videoconference-based telepsychiatry in South Africa.

Authors:  J Chipps; S Ramlall; M Mars
Journal:  Afr J Psychiatry (Johannesbg)       Date:  2012-07

Review 5.  Mobile health applications for HIV prevention and care in Africa.

Authors:  Jamie I Forrest; Matthew Wiens; Steve Kanters; Sabin Nsanzimana; Richard T Lester; Edward J Mills
Journal:  Curr Opin HIV AIDS       Date:  2015-11       Impact factor: 4.283

6.  A Parkinson's disease tele-education program for health care providers in Cameroon.

Authors:  Esther Cubo; Jacques Doumbe; Erero Njiengwe; Paul Onana; Raul Garoña; Josue Alcalde; Joaquin Seco; Natividad Mariscal; Becky Manyi Epundugu; Sixto Cubo; Maria Jesus Coma
Journal:  J Neurol Sci       Date:  2015-07-15       Impact factor: 3.181

7.  Editorial. Task shifting and task sharing for neurosurgeons amidst the COVID-19 pandemic.

Authors:  Faith C Robertson; Laura Lippa; Marike L D Broekman
Journal:  J Neurosurg       Date:  2020-04-17       Impact factor: 5.115

8.  A real-time medical cartography of epidemic disease (Nodding syndrome) using village-based lay mHealth reporters.

Authors:  Raquel Valdes Angues; Austen Suits; Valerie S Palmer; Caesar Okot; Robert A Okot; Concy Atonywalo; Suzanne K Gazda; David L Kitara; Moka Lantum; Peter S Spencer
Journal:  PLoS Negl Trop Dis       Date:  2018-06-15

9.  Impact of using eHealth tools to extend health services to rural areas of Nigeria: protocol for a mixed-method, non-randomised cluster trial.

Authors:  Bassey Ebenso; Matthew John Allsop; Babasola Okusanya; Godwin Akaba; Jamilu Tukur; Kehinde Okunade; David Akeju; Adegbenga Ajepe; Osasuyi Dirisu; Ramsey Yalma; Abubakar Isa Sadeeq; Okey Okuzu; Tolga Ors; Terence Jagger; Joseph Paul Hicks; Tolib Mirzoev; James Nicholas Newell
Journal:  BMJ Open       Date:  2018-10-18       Impact factor: 2.692

View more
  6 in total

1.  Are we there yet? Unbundling the potential adoption and integration of telemedicine to improve virtual healthcare services in African health systems.

Authors:  Elliot Mbunge; Benhildah Muchemwa; John Batani
Journal:  Sens Int       Date:  2021-12-07

2.  Tele-Neurorehabilitation During the COVID-19 Pandemic: Implications for Practice in Low- and Middle-Income Countries.

Authors:  Abhishek Srivastava; Aishwarya Swaminathan; Manigandan Chockalingam; Murali K Srinivasan; Nirmal Surya; Partha Ray; Prasanna S Hegde; Preetie Shetty Akkunje; Sanjivani Kamble; Sonal Chitnis; Sureshkumar Kamalakannan; Suvarna Ganvir; Urvashi Shah
Journal:  Front Neurol       Date:  2021-10-05       Impact factor: 4.003

Review 3.  Utility of telemedicine in sub-Saharan Africa during the COVID-19 pandemic. A rapid review.

Authors:  Itai Chitungo; Malizgani Mhango; Elliot Mbunge; Mathias Dzobo; Godfrey Musuka; Tafadzwa Dzinamarira
Journal:  Hum Behav Emerg Technol       Date:  2021-11-02

Review 4.  The development of telemedicine programs in Sub-Saharan Africa: Progress and associated challenges.

Authors:  Joana Eva Dodoo; Hosam Al-Samarraie; Ahmed Alsswey
Journal:  Health Technol (Berl)       Date:  2021-11-25

5.  Telemedicine in Low- and Middle-Income Countries During the COVID-19 Pandemic: A Scoping Review.

Authors:  Kareem Mahmoud; Catalina Jaramillo; Sandra Barteit
Journal:  Front Public Health       Date:  2022-06-22

Review 6.  The impact of COVID-19 on patients with neurological disorders and their access to healthcare in Africa: A review of the literature.

Authors:  Olivier Uwishema; Kristian Steen Frederiksen; Inês F Silva Correia; Ashraf Mahmoud; Helen Onyeaka; Burhan Dost
Journal:  Brain Behav       Date:  2022-08-11       Impact factor: 3.405

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.